Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D1.105 - Real-Life Evidence of Type 2 Immunomodulation with Benralizumab: From Steroid-Dependent to Controlled Asthma
D1.106 - Dupilumab-Induced Systemic Eosinophilic Immune Activation Mimicking an EGPA-Like Prodrome: A Case Report
D1.108 - Optimization of phenotyping in severe T2-bronchial asthma
D1.109 - Biologics selection algorithm for severe T2-bronchial asthma targeted therapy
D1.110 - Long Term Mepolizumab in Type-2 CRSwNP: Marked Polyp Reduction, Symptom Relief, and Airway Benefits in Real World Comorbid Patients
D1.113 - Effect of mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a real-world retrospective observational study
D1.114 - Efficacy of Radical Endoscopic Surgery Combined with Mepolizumab in Chronic Rhinosinusitis with Nasal Polyps Complicated with Bronchial Asthma: A Real-World research
D1.115 - Real World Assessment of Uncontrolled Severe Asthma in Canada - A Multi-Site Qualitative Survey of Type 2 Inflammatory Biomarkers and Clinical Outcomes
D1.121 - Association of Serum Club Cell Secretory Protein 16 (CC16) with House Dust Mite Sensitization in Children with Asthma
D1.122 - Inspiratory and expiratory airway resistance and expiratory flow limitation in patients with asthma and in response to biological treatment in asthma
D3.80 - Molecular allergy profiling of sensitization in adult patients with asthma in real practice
D3.84 - Patterns of Sensitization to Artemisia and Ambrosia Pollen in Ukraine
D3.90 - Outcomes of Beta-Lactam Allergy Evaluation in Patients with Suspected Hypersensitivity: One-Year Experience
D3.78 - Association between lipocalin sensitization and clinical symptoms: Evidence for cross-reactivity
D3.81 - Allergic Contact Dermatitis Induced by Transdermal Estradiol Hormone Replacement Therapy in a Postmenopausal Patient: A Case Report
D3.82 - Conceptualization of a questionnaire for clinical diagnosis of house dust mite’s allergy
D3.83 - A Case Report of Fenofibrate-Induced Fixed Drug Eruption Documented by Patch Testing and Oral Provocation
D3.86 - ALEX versus ISAC. The same story or an improvement for allergologic molecular diagnostic?
D3.87 - Evaluation of CD63 as a Marker of Basophil Degranulation in the Assessment of IgE-mediated Allergic Immune Responses
D3.89 - Decoding a Triple Pediatric Food Allergy Phenotype Using Component-Resolved Diagnostics: Severe CMPA, Alpha-Gal, and PR-10–Mediated PFAS
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download